INPP4B is a Ptdins(3,4,5)P3 phosphatase that can act as a tumor suppressor

Cancer Discovery

Volumn 5, Issue 7, 2015, Pages 730-739

  Kofuji, Satoshi ^a,b   Kimura, Hirotaka ^a,b   Nakanishi, Hiroki ^a   Nanjo, Hiroshi ^b   Takasuga, Shunsuke ^b   Liu, Hui ^c   Eguchi, Satoshi ^b   Nakamura, Ryotaro ^b   Itoh, Reietsu ^b   Ueno, Noriko ^a   Asanuma, Ken ^b   Huang, Mingguo ^a,b   Koizumi, Atsushi ^b   Habuchi, Tomonori ^b   Yamazaki, Masakazu ^a,b   Suzuki, Akira ^d   Sasaki, Junko ^a   Sasaki, Takehiko ^a,b  

^a AKITA UNIVERSITY   (Japan)

^b AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL POLYPHOSPHATE; INOSITOL POLYPHOSPHATE 4 PHOSPHATASE B; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5-TRIPHOSPHATE; PHOSPHATIDYLINOSITOL-3,4-BISPHOSPHATE 4-PHOSPHATASE; POLYPHOSPHOINOSITIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CANCER GROWTH; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; SOUTHERN BLOTTING; THYROID CANCER; ANIMAL; CELL CULTURE; DEFICIENCY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; MOUSE EMBRYONIC STEM CELL; PATHOLOGY; THYROID TUMOR; TUMOR SUPPRESSOR GENE;

ANIMALS; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; MALE; MICE; MOUSE EMBRYONIC STEM CELLS; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; THYROID NEOPLASMS;

EID: 84937390489     PISSN: 21598274     EISSN: 21598290     Source Type: Journal    
DOI: 10.1158/2159-8290.CD-14-1329     Document Type: Article

References (27)

1. Network TCGAR. Integrated genomic characterization of papillary thyroid carcinoma. Cell 2014; 159: 676-90.
2. Kondo T, Ezzat S, Asa SL. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 2006; 6: 292-306.
3. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 2014; 74: 2913–21.
4. Zhu Z, Gandhi M, Nikiforova MN, Fischer AH, Nikiforov YE. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations. Am J Clin Pathol 2003; 120: 71-7.
5. Sasaki T, Takasuga S, Sasaki J, Kofuji S, Eguchi S, Yamazaki M, et al. Mammalian phosphoinositide kinases and phosphatases. Prog Lipid Res 2009; 48: 307-43.
6. Vanhaesebroeck B, Stephens L, Hawkins P. PI3K signalling: the path to discovery and understanding. Nat Rev Mol Cell Biol 2012; 13: 195–203.
7. Orloff MS, He X, Peterson C, Chen F, Chen JL, Mester JL, et al. Germline PIK3CA and AKT1 mutations in Cowden and Cowden-like syndromes. Am J Hum Genet 2013; 92: 76-80.
8. Eng C. Cowden syndrome. J Genet Counseling 1997; 6: 181-92.
9. Norris FA, Atkins RC, Majerus PW. The cDNA cloning and characterization of inositol polyphosphate 4-phosphatase type II. Evidence for conserved alternative splicing in the 4-phosphatase family. J Biol Chem 1997; 272: 23859-64.
10. Gewinner C, Wang ZC, Richardson A, Teruya-Feldstein J, Etemadmoghadam D, Bowtell D, et al. Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signalling. Cancer Cell 2009; 16: 115-25.
11. Fedele CG, Ooms LM, Ho M, Vieusseux J, O’Toole SA, Millar EK, et al. Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signalling and is lost in human basal-like breast cancers. Proc Natl Acad Sci U S A 2010; 107: 22231-6.
12. Hodgson MC, Shao LJ, Frolov A, Li R, Peterson LE, Ayala G, et al. Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer. Cancer Res 2011; 71: 572-82.
13. Stambolic V, Tsao MS, Macpherson D, Suzuki A, Chapman WB, Mak TW. High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten /− mice. Cancer Res 2000; 60: 3605–11.
14. Suzuki A, de la Pompa JL, Stambolic V, Elia AJ, Sasaki T, del Barco Barrantes I, et al. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol 1998; 8: 1169-78.
15. Yeager N, Klein-Szanto A, Kimura S, Di Cristofano A. Pten loss in the mouse thyroid causes goiter and follicular adenomas: insights into thyroid function and Cowden disease pathogenesis. Cancer Res 2007; 67: 959-66.
16. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012; 2: 401–4.
17. Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013; 6: pl1.
18. Clark J, Anderson KE, Juvin V, Smith TS, Karpe F, Wakelam M J, et al. Quantifi cation of PtdInsP3 molecular species in cells and tissues by mass spectrometry. Nat Methods 2011; 8: 267-72.
19. Yuen JW, Chung GT, Lun SW, Cheung CC, To KF, Lo KW. Epigenetic inactivation of inositol polyphosphate 4-phosphatase B (INPP4B), a regulator of PI3K/AKT signaling pathway in EBV-associated nasopharyngeal carcinoma. PLoS ONE 2014; 9: e105163.
20. Antico-Arciuch VG, Dima M, Liao XH, Refetoff S, Di Cristofano A. Cross-talk between PI3K and estrogen in the mouse thyroid predisposes to the development of follicular carcinomas with a higher incidence in females. Oncogene 2010; 29: 5678-86.
21. Sasaki J, Kofuji S, Itoh R, Momiyama T, Takayama K, Murakami H, et al. The PtdIns(3,4)P(2) phosphatase INPP4A is a suppressor of excitotoxic neuronal death. Nature 2010; 465: 497–501.
22. Sasaki T, Irie-Sasaki J, Jones RG, Oliveira-dos-Santos AJ, Stanford W L, Bolon B, et al. Function of PI3Kg in thymocyte development, T cell activation, and neutrophil migration. Science 2000; 287: 1040-6.
23. Leneuve P, Colnot S, Hamard G, Francis F, Niwa-Kawakita M, Giovannini M, et al. Cre-mediated germline mosaicism: a new transgenic mouse for the selective removal of residual markers from tri-lox conditional alleles. Nucleic Acids Res 2003; 31: e21.
24. Asanuma K, Takasuga S, Sasaki J, Sasaki T. Phosphatidylinositol 3, 5-bisphosphate is an essential regulator of lysosome morphology. Akita J Med 2012; 39:129–37.
25. Maehama T, Taylor GS, Slama JT, Dixon JE. A sensitive assay for phosphoinositide phosphatases. Anal Biochem 2000; 279: 248-50.
26. Lee J, Johnson J, Ding Z, Paetzel M, Cornell RB. Crystal structure of a mammalian CTP: phosphocholine cytidylyltransferase catalytic domain reveals novel active site residues within a highly conserved nucleotidyltransferase fold. J Biol Chem 2009; 284: 33535-48.
27. Takasuga S, Horie Y, Sasaki J, Sun-Wada GH, Kawamura N, Iizuka R, et al. Critical roles of type III phosphatidylinositol phosphate kinase in murine embryonic visceral endoderm and adult intestine. Proc Natl Acad Sci U S A 2013; 110: 1726-31.